Biotricity closes second tranche of Series B Preferred Stock private placement for $500,000

BIOTRICITY INC.

Second closing of 55 shares of Series B Convertible Preferred Stock at $9,090.91/share for gross proceeds of $500,000.
Combined with June 24 first closing (55 shares), total gross proceeds $1M from 110 shares.
Company must seek stockholder approval by August 15, 2024 for conversion-related matters.
Shares sold under Regulation D exemption; unregistered securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.